Defining distinct features of anti-MOG antibody associated central nervous system demyelination - Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück, 2018
Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD) - ScienceDirect
MOG (E5K6T) XP® Rabbit mAb | Cell Signaling Technology
The pathological features of MOG antibody-positive cerebral cortical encephalitis as a new spectrum associated with MOG antibodies: A case report - Journal of the Neurological Sciences
Myelin-oligodendrocyte glycoprotein antibody-associated disease - The Lancet Neurology
Spectrum of MOG antibody-associated disorders. | Download Scientific Diagram
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD